A meta-analysis has concluded that amyloid-beta1-42 in CSF is useful for discriminating Alzheimer’s disease from controls (Rosa et al. J Alzheimers Dis 2014; epublished January 21, 2014).
It takes 30 seconds or login using your email address
Please enter the email address that you registered the newsletter with
